Evidence map›Paper›PMID 29333915›Full record

ArticleDevelopmental neurorehabilitation2018

Gaze avoidance and perseverative language in fragile X syndrome and autism spectrum disorder: brief report.

Laura Friedman, Audra Sterling, Andrea Barton-Hulsey

Abstract read
In one paragraph

Article in Developmental neurorehabilitation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Laura Friedmana Department of Communication Sciences and Disorders , University of Wisconsin-Madison , Madison , WI , USA.
Audra Sterlinga Department of Communication Sciences and Disorders , University of Wisconsin-Madison , Madison , WI , USA.
Andrea Barton-Hulseyb University of Wisconsin-Madison, Waisman Center , Madison , WI , USA.

Funding

WISCONSIN CENTER ON MENTAL RETARDATION: CORE SUPPORTP30HD003352 · NICHD · UNIVERSITY OF WISCONSIN-MADISON · PI MESSING, ALBEE · 1985 to 2015
$25.2M
POSTDOCTORAL TRAINING IN MENTAL RETARDATION RESEARCHT32HD007489 · NICHD · UNIVERSITY OF WISCONSIN-MADISON · PI Sigan L Hartley · 1995 to 2026
$6.0M
Interdisciplinary Training in Speech-Language DisordersT32DC005359 · NIDCD · UNIVERSITY OF WISCONSIN-MADISON · PI ELLIS-WEISMER, SUSAN · 2002 to 2019
$3.7M
Grammatical Development in Boys with Fragile X Syndrome and AutismR03DC011616 · NIDCD · UNIVERSITY OF WISCONSIN-MADISON · PI STERLING, AUDRA MARIE · 2011 to 2013
$438k
NICHD NIH HHS P30 HD003352NICHD NIH HHS T32 HD007489NIDCD NIH HHS R03 DC011616NIDCD NIH HHS T32 DC005359
6 · The paper itself

Abstract

Gaze avoidance and perseverative language impact pragmatics in autism spectrum disorder (ASD) and fragile X syndrome (FXS). We examined these features during conversation samples in boys with ASD (n = 10) and boys with FXS and ASD (FXS+ASD; n = 10). Both groups had similar high rates of gaze avoidance and topic and conversation device perseverations, yet these features were not correlated with one another. Boys with FXS+ASD produced a higher proportion of single utterance perseverations. Results from this study highlight the need for future research to identify potential mechanisms influencing the presence of language perseverations and gaze avoidance.

Indexed as

Fixation, OcularLanguageAutism Spectrum DisorderChildFragile X SyndromeHumansMaleSocial BehaviorAutism spectrum disordereye gaze avoidancefragile X syndromeperseverative languagepragmatics

Identifiers

PMID29333915
PMCPMC6236677

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.